---
reference_id: "PMID:30342581"
title: Immunoglobulin E as a Biomarker in Asthma.
authors:
- Rath N
- Raje N
- Rosenwasser L
journal: Immunol Allergy Clin North Am
year: '2018'
doi: 10.1016/j.iac.2018.06.007
content_type: abstract_only
---

# Immunoglobulin E as a Biomarker in Asthma.
**Authors:** Rath N, Raje N, Rosenwasser L
**Journal:** Immunol Allergy Clin North Am (2018)
**DOI:** [10.1016/j.iac.2018.06.007](https://doi.org/10.1016/j.iac.2018.06.007)

## Content

1. Immunol Allergy Clin North Am. 2018 Nov;38(4):587-597. doi: 
10.1016/j.iac.2018.06.007. Epub 2018 Jul 31.

Immunoglobulin E as a Biomarker in Asthma.

Rath N(1), Raje N(1), Rosenwasser L(2).

Author information:
(1)Allergy/Immunology, Children's Mercy Hospital, University of Missouri Kansas 
City School of Medicine, 2401 Gillham Road, Kansas City, MO 64108, USA.
(2)Allergy/Immunology, University of Missouri Kansas City School of Medicine, 
2411 Holmes Street, Kansas City, MO 64108, USA. Electronic address: 
lrosenwasser334@gmail.com.

Asthma is a chronic disease that affects children and adults with significant 
morbidity and mortality. It is multifactorial, with genetic and environmental 
factors affecting the overall course of the disease. Both specific and total 
immunoglobulin (Ig)E can be used in specific phenotypes such as allergic asthma. 
Using IgE as a biomarker for asthma provides a target for management and 
treatment. Biotherapeutics continue to emerge as important advances in asthma 
treatment, and their effect on IgE and its biomarker role continue to be 
studied.

Copyright Â© 2018 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.iac.2018.06.007
PMID: 30342581 [Indexed for MEDLINE]